Institutional investors purchased a net $694.6 thousand shares of SRPT during the quarter ended December 2015, and now own 64.20% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 25.9 Thousand shares of Sarepta Therapeutics Inc
ACUITY CAPITAL MANAGEMENT LLC Bought 4.4 Thousand shares of Sarepta Therapeutics Inc